Contributions of Electromigration and Electroosmosis to Iontophoretic Drug Delivery
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Purpose. To determine the electromigration and electroosmotic contributions to the iontophoretic delivery of lidocaine hydrochloride, in addition to the more-lipophilic quinine and propranolol hydrochlorides, in the presence and absence of background electrolyte.
Methods: In vitro experiments, using excised pig ear skin and both vertical and side-by-side diffusion cells, were performed as a function of drug concentration and with and without background electrolytes in the anodal formulation. Concomitantly, the contribution of electroosmosis in each experimental configuration was monitored by following the transport of the neutral, polar marker molecule, mannitol.
Results. Electromigration was the dominant mechanism of drug iontophoresis (typically representing ∼90% of the total flux). In the presence of background electrolyte, lidocaine delivery increased linearly with concentration as it competed more and more effectively with Na+ to carry the charge across the skin. However, iontophoretic delivery of quinine and propranolol increased non-linearly with concentration. Without electrolytes, on the other hand, electrotransport of the three drugs was essentially independent of concentration over the range 1-100 mM. Transport efficiency of lidocaine was ∼10%, whereas that of the more lipophilic compounds was significanly less, with the major charge carrier being Cl− moving from beneath the skin into the anodal chamber. Both quinine and propranolol induced a concentration-dependent attenuation of electroosmotic flow in the normal anode-to-cathode direction.
Conclusion. Dissecting apart the mechanistic contributions to iontophoretic drug delivery is key to the optimization of the formulation, and to the efficient use of the drug substance.
- Kim, A., Green, P. G., Rao, G., Guy, R. H. (1993) Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10: pp. 1315-1320
- Guy, R. H., Kalia, Y. N., Delgado-Charro, M. B., Merino, V., López, A., Marro, D. (2000) Iontophoresis: Electrorepulsion and electroosmosis. J. Control. Release 64: pp. 129-132
- Luzardo-Álvarez, A., Rodríguez-Fernández, M., Blanco-Méndez, J., Guy, R. H., Delgado-Charro, M. B. (1998) Iontophoretic permselectivity of mammalian skin: characterization of hairless mouse and porcine membrane models. Pharm. Res. 15: pp. 984-987
- Merino, V., López, A., Kalia, Y. N., Guy, R. H. (1999) Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res. 16: pp. 758-761
- Bath, B. D., White, H. S., Scott, E. R. (2000) Visualization and analysis of electroosmotic flow in hairless mouse skin. Pharm. Res. 17: pp. 471-475
- Marro, D., Guy, R. H., Delgado-Charro, M. B. (2001) Characterization of the iontophoretic permselectivity properties of human and pig skin. J. Control. Release 70: pp. 213-217
- Burnette, R. R., Ongpipattanakul, B. (1987) Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76: pp. 765-773
- Pikal, M. J. (1992) The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 9: pp. 201-237
- http://www.bd.com/pharmaceuticals/products/transdermal/safety.html (visited Nov. 2000).
- Hirvonen, J., Guy, R. H. (1997) Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm. Res. 14: pp. 1258-1263
- Delgado-Charro, M.B., Guy, R.H. (1994) Characterization of convective solvent flow during iontophoresis. Pharm. Res. 11: pp. 929-935
- Delgado-Charro, M. B., Guy, R. H. (1995) Iontophoretic delivery of Nafarelin across the skin. Int. J. Pharm. 117: pp. 165-172
- Hirvonen, J., Kalia, Y. N., Guy, R.H. (1996) Transdermal delivery of peptides by iontophoresis. Nat. Biotech. 14: pp. 1710-1713
- Hirvonen, J., Guy, R. H. (1998) Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J. Control. Release 50: pp. 283-289
- Hoogstraate, A. H., Srinivasan, V., Sims, S. M., Higuchi, W. I. (1994) Iontophoretic enhancement of peptides: behaviour of leuprolide versus model permeants. J. Control. Release 31: pp. 41-47
- Glikfeld, P., Cullander, C., Hinz, R. S., Guy, R. H. (1988) A new system for in vitro studies of iontophoresis. Pharm. Res. 5: pp. 443-446
- Delgado-Charro, M. B., Rodríguez-Bayón, A. M., Guy, R. H. (1995) Iontophoresis of nafarelin: effects of current density and concentration on electrotransport in vitro. J. Control. Release 35: pp. 35-40
- Kasting, G. B., Keister, J. C. (1989) Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J. Control. Release 8: pp. 195-210
- Marro, D., Kalia, Y. N., Delgado-Charro, M.B., Guy, R. H. (2001) Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species. Pharm. Res. 18: pp. 1708-1712
- Lai, P. M., Roberts, M. S. (1998) Epidermal iontophoresis: II. Application of the ionic mobility-pore model to the transport of local anesthetics. Pharm. Res. 15: pp. 1579-1588
- Santi, P., Guy, R. H. (1996) Reverse iontophoresis-parameters determining electroosmotic flow. I. pH and ionic strength. J. Control. Release 38: pp. 159-165
- Contributions of Electromigration and Electroosmosis to Iontophoretic Drug Delivery
Volume 18, Issue 12 , pp 1701-1708
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- transdermal delivery
- Industry Sectors
- Author Affiliations
- 1. Centre interuniversitaire de recherche et d'enseignement, Universities of Geneva and Lyon, “Pharmapeptides,”, F-74166, Archamps, France
- 2. University of Geneva, Faculté des Sciences, Section de Pharmacie, 30, quai E. Ansermet, CH-1211, Geneva 4, Switzerland